In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials (PDQ®)

  • First Published: 12/3/2007
  • Last Modified: 2/10/2012

Page Options

  • Print This Page
  • Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Phase III Randomized Study of Prostate Bed Radiotherapy (PBRT) Alone Versus Short Term Androgen Deprivation Comprising Antiandrogen and Luteinizing Hormone-Releasing Hormone Agonist Therapy and Pelvic Lymph Node Radiotherapy With Versus Without PBRT in Patients With a Rising Prostate-Specific Antigen After Radical Prostatectomy for Prostate Cancer

Alternate Title
Basic Trial Information
Objectives
Entry Criteria
Expected Enrollment
Outcomes
Outline
Trial Contact Information
Registry Information

Alternate Title

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate Cancer

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IIITreatmentActive18 and overNCIRTOG-0534
RTOG 0534, NCT00567580

Special Category: CTSU trial

Objectives

Primary

  1. To determine whether the addition of short-term androgen deprivation (STAD) to prostate bed radiotherapy (PBRT) improves freedom from progression (FFP) (i.e., maintenance of a prostate-specific antigen [PSA] less than the nadir+2 ng/mL, absence of clinical failure, and absence of death from any cause) for 5 years, over that of PBRT alone in men treated with salvage radiotherapy after radical prostatectomy.
  2. To determine whether STAD, pelvic lymph node radiotherapy (PLNRT), and PBRT improves FFP over that of STAD+PBRT and PBRT alone in men treated with salvage radiotherapy after radical prostatectomy.

Secondary

  1. To compare the rates of a PSA ≥ 0.4 ng/mL and rising at 5 years after randomization (secondary biochemical failure endpoint), the development of hormone-refractory disease (3 rises in PSA during treatment with salvage androgen-deprivation therapy), distant metastasis, cause-specific mortality, and overall mortality.
  2. To compare acute and late morbidity based on CTCAE, v. 3.0.
  3. To measure the expression of cell kinetic, apoptotic pathway, and angiogenesis-related genes in archival diagnostic tissue to better define the risk of FFP, distant failure, cause-specific mortality, and overall mortality after salvage radiotherapy for prostate cancer, independently of conventional clinical parameters now used.
  4. To quantify blood product-based proteomic and genomic (single nucleotide polymorphisms) patterns and urine-based genomic patterns before and at different times after treatment to better define the risk of FFP, distant failure, cause-specific mortality, and overall mortality after salvage radiotherapy for prostate cancer, independently of conventional clinical parameters now used.
  5. To assess the degree, duration, and significant differences of disease-specific health-related quality of life (HRQOL) decrements among treatment arms.
  6. To assess whether mood is improved and depression is decreased with the more aggressive therapy if it improves FFP.
  7. To collect paraffin-embedded tissue blocks, serum, plasma, urine, and buffy coat cells for future translational research analyses.

Tertiary

  1. To assess whether an incremental gain in FFP and survival with more aggressive therapy outweighs decrements in the primary generic domains of HRQOL (i.e., mobility, self care, usual activities, pain/discomfort, and anxiety/depression).
  2. To evaluate the cost-utility of the treatment arm demonstrating the most significant benefit (in terms of the primary outcome) in comparison with other widely accepted cancer and non-cancer therapies.
  3. To assess associations between serum levels of beta-amyloid and measures of cognition and mood and depression.
  4. An exploratory aim is to assess the relationship(s) between the American Urological Association Symptom Index (AUA SI) and urinary morbidity using the CTCAE v. 3.0 grading system.

Entry Criteria

Disease Characteristics:

  • Adenocarcinoma of the prostate treated primarily with radical prostatectomy
    • Pathologically proven to be lymph node-negative by pelvic lymphadenectomy (N0) or lymph node status pathologically unknown (Nx [undissected pelvic lymph nodes because lymph node dissection is not required])
    • Any type of radical prostatectomy allowed, including retropubic, perineal, laparoscopic, or robotically assisted
    • Meets 1 of the following pathologic classifications:
      • T3 N0/Nx disease with or without positive prostatectomy margins
      • T2 N0/Nx disease with or without positive prostatectomy margins
    • N1 patients are ineligible, as are those with pelvic lymph node enlargement ≥ 1.5 cm in greatest dimension by CT scan or MRI of the pelvis, unless the enlarged lymph node is negative
    • Prostatectomy Gleason score of 9 or less

  • A post-radical prostatectomy entry PSA of ≥ 0.1 and ≤ 1.0 ng/mL at least 6 weeks after prostatectomy and within 30 days of registration

  • Serum total testosterone ≥ 40% of the lower limit of normal (patients who have had a unilateral orchiectomy are eligible as long as this requirement is met)

  • No distant metastases based on history/physical examination, CT scan or MRI of the abdomen and pelvis, and bone scan

  • No palpable prostatic fossa abnormality/mass suggestive of recurrence, unless shown by biopsy under ultrasound guidance not to contain cancer

Prior/Concurrent Therapy:

  • See Disease Characteristics
  • More than 5 years since prior chemotherapy for any other disease site
  • No androgen-deprivation therapy started prior to prostatectomy for > 6 months duration
    • The use of finasteride or dutasteride (± tamsulosin) for longer periods prior to prostatectomy is acceptable
  • No androgen-deprivation therapy started after prostatectomy and prior to registration
    • The use of finasteride or dutasteride (± tamsulosin) after prostatectomy is not acceptable, it must be stopped within 3 months after prostatectomy
  • No neoadjuvant chemotherapy before or after prostatectomy
  • No prior cyrosurgery or brachytherapy of the prostate (prostatectomy should be the primary treatment and not a salvage procedure)
  • No prior pelvic radiotherapy

Patient Characteristics:

  • Zubrod performance status 0-1
  • Platelets ≥ 100,000/mm3
  • Hemoglobin ≥ 10.0 g/dL (the use of transfusion or other intervention to achieve this is allowed)
  • AST or ALT < 2 x upper limit of normal
  • No prior invasive malignancy (except nonmelanoma skin cancer) or superficial bladder cancer unless disease free for a minimum of 5 years (e.g., carcinoma in situ of the oral cavity is permissible)
  • No severe, active co-morbidity, including any of the following:
    • History of inflammatory bowel disease
    • History of hepatitis B or C
    • Unstable angina and/or congestive heart failure requiring hospitalization within the past 6 months
    • Transmural myocardial infarction within the past 6 months
    • Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
    • Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration
    • Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects
    • Acquired immune deficiency syndrome (AIDS) based upon current CDC definition
      • HIV testing is not required for entry
  • No prior allergic reaction to the study drug(s) involved in this protocol

Expected Enrollment

1764

Outcomes

Primary Outcome(s)

Freedom from progression (FFP)

Secondary Outcome(s)

Secondary biochemical failure
Hormone-refractory disease
Local failure
Distant metastasis
Cause-specific mortality
Overall mortality
Incidence of acute adverse events ≤ 90 days of the completion of radiotherapy (RT)
Time to late grade 2+ and 3+ adverse events assessed > 90 days from the completion of RT
Comparison of disease-specific health related quality of life (HRQOL) change by EPIC, HVLT-R, Trail Making Test, parts A & B, and COWAT
Assessment of mood and depression change using QOL measured by the HSCL-25
Assessment and comparison of Quality Adjusted Life Year (QALY) and Quality Adjusted FFP Year (QAFFPY)
Evaluation and comparison of the cost-utility using EQ-5D
Association between serum levels of beta-amyloid (Abeta) and measures of HSCL-25, the HVLT-R, Trail Making Test, parts A & B, or the COWAT
Prognostic value of genomic and proteomic markers for the primary and secondary clinical endpoints
Collection of paraffin-embedded tissue blocks, serum, plasma, urine, and buffy coat cells for future translational research analyses
Assessment of the relationship(s) between the American Urological Association Symptom Index (AUA SI) and urinary morbidity (Adverse Event terms: Urinary frequency/urgency) using the CTCAE v. 3.0 grading system

Outline

Patients are stratified according to seminal vesicle involvement (yes vs no), prostatectomy Gleason score (≤ 7 vs 8-9), pre-radiotherapy PSA (≥ 0.1 and ≤ 1.0 ng/mL vs > 1.0 and < 2.0 ng/mL), and pathology stage (pT2 and margin negative vs all others). Patients are randomized to 1 of 3 treatment arms.

  • Arm I (prostate bed radiotherapy [PBRT] alone): Patients undergo PBRT once daily, 5 days a week, Monday through Friday, for approximately 7-8 weeks (36 to 39 fractions).

  • Arm II (PBRT and short-term androgen-deprivation [STAD]): Beginning 2 months before the start of PBRT, patients undergo STAD, using a combination of antiandrogen and luteinizing hormone-releasing hormone (LHRH) agonist therapy, for a total of 4-6 months. Patients receive antiandrogen therapy comprising either oral flutamide 3 times daily or oral bicalutamide once daily for at least 4 months (started within 1-14 days prior to the LHRH agonist and ending the last day of radiotherapy ± 14 days). Patients receive LHRH agonist injection beginning concurrently with or 2 weeks after the start of antiandrogen therapy. LHRH agonist injection consists of analogs approved by the FDA (or by Health Canada for Canadian institutions) (e.g., leuprolide, goserelin, buserelin, or triptorelin) and may be given in any possible combination (may be given as a single 4-month injection and one to two 1-month injection[s], two 3-month injections, or a 6-month injection), such that the total LHRH agonist treatment time is 4-6 months. Approximately 2 months after beginning of STAD, patients undergo PBRT as in arm I.

  • Arm III (Pelvic lymph node radiotherapy [PLNRT], PBRT, and STAD): Beginning 2 months before the start of radiotherapy, patients receive STAD therapy as in arm II. Approximately 2 months after beginning of STAD, patients undergo PBRT and PLNRT once daily, 5 days a week, Monday through Friday, for approximately 5 weeks (25 fractions) followed by PBRT only once daily, 5 days a week for approximately 2-3 weeks (11-14 fractions).

Patients complete the American Urological Association Symptom Index (AUA SI) questionnaire prior to protocol treatment, at week 6 of radiotherapy, and then periodically after completion of study therapy.

After completion of study therapy, patients are followed up every 3 months for 1 year, every 6 months for 4 years, and then annually thereafter.

Trial Contact Information

Trial Lead Organizations

Radiation Therapy Oncology Group

Alan Pollack, MD, PhD, Protocol chair
Ph: 215-728-2940; 888-369-2427
Email: alan.pollack@fccc.edu
Leonard Gomella, MD, Protocol co-chair
Ph: 215-955-6961
Email: leonard.gomella@mail.tju.edu

Cancer and Leukemia Group B

Joycelyn Speight, MD, PhD, Protocol chair
Ph: 415-353-7175; 800-888-8664

Trial Sites

U.S.A.
Alabama
  Birmingham
 UAB Comprehensive Cancer Center
 Clinical Trials Office - UAB Comprehensive Cancer Center
Ph: 205-934-0309
Alaska
  Fairbanks
 Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
 Huong Pham, MD
Ph: 206-223-6801
Arizona
  Peoria
 Arizona Center for Cancer Care - Peoria
 Terry Lee
Ph: 623-773-2873
  Phoenix
 Arizona Oncology Services Foundation
 David Brachman, MD, FACRO
Ph: 602-274-4484
  Tucson
 Arizona Cancer Center at University of Arizona Health Sciences Center
 Clinical Trials Office - Arizona Cancer Center at University of Arizona Health Sciences Center
Ph: 520-626-9008
 Arizona Oncology - Tucson
 Vivek Kavadi
Ph: 520-797-4468
California
  Auburn
 Auburn Radiation Oncology
 Christopher Jones, MD
Ph: 916-646-6600
  Berkeley
 Alta Bates Summit Comprehensive Cancer Center
 Clinical Trials Office - Alta Bates Summit Comprehensive Cancer Center
Ph: 510-204-3428
  Burlingame
 Peninsula Medical Center
 David Irwin, MD
Ph: 510-204-1591
  Cameron Park
 Radiation Oncology Centers - Cameron Park
 Christopher Jones, MD
Ph: 916-646-6600
  Carmichael
 Mercy Cancer Center at Mercy San Juan Medical Center
 Christopher Jones, MD
Ph: 916-646-6600
  Castro Valley
 East Bay Radiation Oncology Center
 James Feusner, MD
Ph: 510-428-3689
 Valley Medical Oncology Consultants - Castro Valley
 James Feusner, MD
Ph: 510-428-3689
  Chico
 Enloe Cancer Center at Enloe Medical Center
 Clinical Trials Office - Enloe Cancer Center at Enloe Medical Center
Ph: 530-332-3808
  Duarte
 City of Hope Comprehensive Cancer Center
 Clinical Trials Office - City of Hope Comprehensive Cancer Center
Ph: 800-826-4673
  Email: becomingapatient@coh.org
  Fremont
 Valley Medical Oncology
 James Feusner, MD
Ph: 510-428-3689
 Washington Township Hospital
 Vandana Sharma
Ph: 510-797-1111
  Fresno
 California Cancer Center - Woodward Park Office
 Brent Kane
Ph: 559-447-4050
  Long Beach
 Veterans Affairs Medical Center - Long Beach
 Samar Azawi, MD
Ph: 562-826-5606
  Los Angeles
 Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
 Howard Sandler, MD
Ph: 734-936-9338
 USC/Norris Comprehensive Cancer Center and Hospital
 Clinical Trials Office - USC/Norris Comprehensive Cancer Center and Hospital
Ph: 323-865-0451
  Martinez
 Contra Costa Regional Medical Center
 James Feusner, MD
Ph: 510-428-3689
  Mission Hills
 Providence Holy Cross Cancer Center
 Philip Beron
Ph: 818-898-4410
  Modesto
 Memorial Medical Center
 Clinical Trials Office - Memorial Medical Center
Ph: 209-572-7116
  Mountain View
 El Camino Hospital Cancer Center
 Clinical Trials Office - El Camino Hospital Cancer Center
Ph: 650-988-7623
  Novato
 Sutter Health - Western Division Cancer Research Group
 David Irwin, MD
Ph: 510-204-1591
  Oakland
 Alta Bates Summit Medical Center - Summit Campus
 Clinical Trials Office - Alta Bates Summit Medical Center - Summit Campus
Ph: 510-204-1414
 Bay Area Breast Surgeons, Incorporated
 James Feusner, MD
Ph: 510-428-3689
 CCOP - Bay Area Tumor Institute
 James Feusner, MD
Ph: 510-428-3689
 Larry G Strieff MD Medical Corporation
 James Feusner, MD
Ph: 510-428-3689
 Tom K Lee, Incorporated
 James Feusner, MD
Ph: 510-428-3689
  Orange
 St. Joseph Hospital Regional Cancer Center - Orange
 Robert Ash
Ph: 714-771-8999
  Palo Alto
 Palo Alto Medical Foundation
 David Irwin, MD
Ph: 510-204-1591
  Paradise
 Feather River Hospital Cancer Center
 Sam Mazj
Ph: 530-876-3144
  Pomona
 Robert and Beverly Lewis Family Cancer Care Center at Pomona Valley Hospital Medical Center
 Clinical Trials Office - Robert and Beverly Lewis Family Cancer Care Center
Ph: 909-865-9555
  Roseville
 Radiation Oncology Center - Roseville
 Christopher Jones, MD
Ph: 916-646-6600
  Sacramento
 Mercy General Hospital
 Christopher Jones, MD
Ph: 916-646-6600
 Radiological Associates of Sacramento Medical Group, Incorporated
 Christopher Jones, MD
Ph: 916-646-6600
 University of California Davis Cancer Center
 Clinical Trials Office - University of California Davis Cancer Center
Ph: 916-734-3089
  Saint Helena
 Saint Helena Hospital
 David Tate
Ph: 707-963-3611
  San Francisco
 California Pacific Medical Center - California Campus
 David Irwin, MD
Ph: 510-204-1591
 UCSF Helen Diller Family Comprehensive Cancer Center
 Clinical Trials Office - UCSF Helen Diller Family Comprehensive Cancer Center
Ph: 877-827-3222
  Vacaville
 Solano Radiation Oncology Center
 Christopher Jones, MD
Ph: 916-646-6600
  Vallejo
 Sutter Solano Medical Center
 David Irwin, MD
Ph: 510-204-1591
Colorado
  Aurora
 Aurora Presbyterian Hospital
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Boulder
 Boulder Community Hospital
 Clinical Trials Office - Boulder Community Hospital
Ph: 303-938-5253
  Denver
 Porter Adventist Hospital
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
 Presbyterian - St. Luke's Medical Center
 Clinical Trials Office - Presbyterian - St. Luke's Medical Center
Ph: 303-839-6000
 St. Joseph Hospital
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Englewood
 Swedish Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Grand Junction
 St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Greeley
 North Colorado Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Longmont
 Hope Cancer Care Center at Longmont United Hospital
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Loveland
 McKee Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Pueblo
 St. Mary - Corwin Regional Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Thornton
 North Suburban Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Wheat Ridge
 Exempla Lutheran Medical Center
 Clinical Trials Office - Exempla Lutheran Medical Center
Ph: 303-403-3605
Connecticut
  Middletown
 Middlesex Hospital Cancer Center
 Joseph Weissberg, MD
Ph: 860-358-2100
  Norwich
 Eastern Connecticut Hematology and Oncology Associates
 Dennis Slater, MD
Ph: 860-886-8362
 William W. Backus Hospital
 Dennis Slater, MD
Ph: 860-886-8362
Delaware
  Newark
 CCOP - Christiana Care Health Services
 Clinical Trial Office - CCOP - Christiana Care Health Services
Ph: 302-623-4450
District of Columbia
  Washington
 Washington Cancer Institute at Washington Hospital Center
 Clinical Trials Office - Washington Cancer Institute
Ph: 202-877-8839
Florida
  Gainesville
 University of Florida Shands Cancer Center
 Clinical Trials Office - University of Florida Shands Cancer Center
Ph: 888-254-7581
  Jacksonville
 Baptist Cancer Institute - Jacksonville
 Clinical Trials Office - Baptist Cancer Institute - Jacksonville
Ph: 904-202-7051
 Integrated Community Oncology Network at Southside Cancer Center
 Douglas Johnson, MD
Ph: 904-202-2273
  Jacksonville Beach
 Integrated Community Oncology Network
 Douglas Johnson, MD
Ph: 904-202-2273
  Jascksonville
 Baptist Medical Center South
 Douglas Johnson, MD
Ph: 904-202-2273
  Orange Park
 Integrated Community Oncology Network - Orange Park
 Douglas Johnson, MD
Ph: 904-202-2273
  Orlando
 Florida Hospital Cancer Institute at Florida Hospital Orlando
 Clinical Trials Office - Florida Hospital Cancer Institute
Ph: 407-303-5623
  Palatka
 Florida Cancer Center - Palatka
 Douglas Johnson, MD
Ph: 904-202-2273
  Panama City
 Bay Medical
 Hasan Murshed
Ph: 850-747-6972
  Saint Augustine
 Flagler Cancer Center
 Douglas Johnson, MD
Ph: 904-202-2273
  Tampa
 Veterans Affairs Medical Center - Tampa
 Babu Zachariah, MD
Ph: 813-972-7667
Georgia
  Atlanta
 Emory Crawford Long Hospital
 Peter Rossi
Ph: 404-686-4411
 Georgia Cancer Center for Excellence at Grady Memorial Hospital
 Peter Rossi
Ph: 404-489-9000
 Piedmont Hospital
 Adam Nowlan
Ph: 404-605-5000
866-605-5111
 Winship Cancer Institute of Emory University
 Clinical Trials Office - Winship Cancer Institute
Ph: 404-778-1900
  Columbus
 John B. Amos Cancer Center
 Clinical Trials Office - John B. Amos Cancer Center
Ph: 706-660-6404
  Gainesville
 Northeast Georgia Medical Center
 Frank Lake, MD
Ph: 770-535-3393
  Savannah
 Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler
 John Pablo
Ph: 912-819-6000
Hawaii
  Aiea
 Kapiolani Medical Center at Pali Momi
 Paul DeMare, MD, FACR
Ph: 808-547-4771
  Honolulu
 Cancer Research Center of Hawaii
 Clinical Trials Office - Cancer Research Center of Hawaii
Ph: 808-586-2979
 Hawaii Medical Center - East
 Paul DeMare, MD, FACR
Ph: 808-547-4771
 Queen's Cancer Institute at Queen's Medical Center
 Paul DeMare, MD, FACR
Ph: 808-547-4771
 Straub Clinic and Hospital, Incorporated
 Paul DeMare, MD, FACR
Ph: 808-547-4771
  Wailuku
 Pacific Cancer Institute - Maui
 Paul DeMare, MD, FACR
Ph: 808-547-4771
Idaho
  Boise
 Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
 Clinical Trials Office - Saint Alphonsus Cancer Care Center
Ph: 208-367-7954
Illinois
  Chicago
 Robert H. Lurie Comprehensive Cancer Center at Northwestern University
 Clinical Trials Office - Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Ph: 312-695-1301
  Email: cancer@northwestern.edu
 Rush University Medical Center
 Clinical Trials Office - Rush University Medical Center
Ph: 312-942-5498
  Email: clinical_trials@rush.edu
 University of Chicago Cancer Research Center
 Clinical Trials Office - University of Chicago Cancer Research Center
Ph: 773-834-7424
  Decatur
 Decatur Memorial Hospital Cancer Care Institute
 Clinical Trials Office - Decatur Memorial Hospital Cancer Care Institute
Ph: 217-876-4750
  Freeport
 Leonard C. Ferguson Cancer Center
 Gregory Richards
Ph: 815-599-7000
  Harvey
 Ingalls Cancer Care Center at Ingalls Memorial Hospital
 Clinical Trials Office - Ingalls Cancer Care Center at Ingalls Memorial Hospital
Ph: 708-915-4673
  Hines
 Veterans Affairs Medical Center - Hines
 Nirmala Bhoopalam, MD
Ph: 708-202-2782
  Maywood
 Cardinal Bernardin Cancer Center at Loyola University Medical Center
 Clinical Trials Office - Cardinal Bernardin Cancer Center
Ph: 708-226-4357
  Moline
 Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
 Costas Constantinou, MD
Ph: 563-359-9876
  Springfield
 Cancer Institute at St. John's Hospital
 Cathy Clausen, MD
Ph: 765-646-8358
 Regional Cancer Center at Memorial Medical Center
 Clinical Trials Office - Regional Cancer Center at Memorial Medical Center
Ph: 217-788-4233
Indiana
  Elkhart
 Elkhart General Hospital
 David Hornback, MD
Ph: 574-647-7461
  Fort Wayne
 Parkview Regional Cancer Center at Parkview Health
 Brian Chang
Ph: 260-373-7850
 Radiation Oncology Associates Southwest
 Brian Chang
Ph: 260-436-4116
  Goshen
 Center for Cancer Care at Goshen General Hospital
 Clinical Trials Office - Center for Cancer Care at Goshen General Hospital
Ph: 574-535-2858
  Indianapolis
 Central Indiana Cancer Centers - East
 Vivek Kavadi
Ph: 317-964-5200
 Indiana University Melvin and Bren Simon Cancer Center
 Clinical Trials Office - Indiana University Cancer Center
Ph: 317-274-2552
 Veterans Affairs Medical Center - Indianapolis
 Peter Johnstone, MD
Ph: 404-778-3473
  Kokomo
 Howard Community Hospital
 David Hornback, MD
Ph: 574-647-7461
  La Porte
 Center for Cancer Therapy at LaPorte Hospital and Health Services
 David Hornback, MD
Ph: 574-647-7461
  Mishawaka
 Saint Joseph Regional Medical Center
 David Hornback, MD
Ph: 574-647-7461
  Muncie
 Cancer Center at Ball Memorial Hospital
 Clinical Trials Office - Cancer Center at Ball Memorial Hospital
Ph: 765-281-2107
  South Bend
 CCOP - Northern Indiana CR Consortium
 David Hornback, MD
Ph: 574-647-7461
 Memorial Hospital of South Bend
 Clinical Trials Office - Memorial Hospital of South Bend
Ph: 800-284-7370
Iowa
  Des Moines
 CCOP - Iowa Oncology Research Association
 Robert Behrens
Ph: 515-244-7586
888-244-6061
 John Stoddard Cancer Center at Iowa Lutheran Hospital
 Clinical Trials Office - John Stoddard Cancer Center at Iowa Lutheran Hospital
Ph: 515-241-8704
 John Stoddard Cancer Center at Iowa Methodist Medical Center
 Clinical Trials Office - John Stoddard Cancer Center at Iowa Methodist Medical Center
Ph: 515-241-6727
 Medical Oncology and Hematology Associates at John Stoddard Cancer Center
 Robert Behrens
Ph: 515-282-2921
 Medical Oncology and Hematology Associates at Mercy Cancer Center
 Robert Behrens
Ph: 515-643-8740
 Mercy Cancer Center at Mercy Medical Center - Des Moines
 Robert Behrens
Ph: 515-643-8206
888-221-4849
  Dubuque
 Wendt Regional Cancer Center at Finley Hospital
 Nagendra (Bobby) Koneru
Ph: 563-589-2468
800-397-2467
  Sioux City
 Mercy Medical Center - Sioux City
 Donald Wender, MD, PhD
Ph: 712-252-0088
 Siouxland Hematology-Oncology Associates, LLP
 Donald Wender, MD, PhD
Ph: 712-252-0088
 St. Luke's Regional Medical Center
 Donald Wender, MD, PhD
Ph: 712-252-0088
Kansas
  Dodge City
 Cancer Center of Kansas, PA - Dodge City
 Shaker Dakhil, MD, FACP
Ph: 316-262-4467
  El Dorado
 Cancer Center of Kansas, PA - El Dorado
 Shaker Dakhil, MD, FACP
Ph: 316-262-4467
  Lawrence
 Lawrence Memorial Hospital
 Shaker Dakhil, MD, FACP
Ph: 316-262-4467
  Wellington
 Cancer Center of Kansas, PA - Wellington
 Shaker Dakhil, MD, FACP
Ph: 316-262-4467
  Wichita
 Associates in Womens Health, PA - North Review
 Shaker Dakhil, MD, FACP
Ph: 316-262-4467
 Cancer Center of Kansas, PA - Wichita
 Shaker Dakhil, MD, FACP
Ph: 316-262-4467
 Cancer Center of Kansas, PA - Medical Arts Tower
 Shaker Dakhil, MD, FACP
Ph: 316-262-4467
 CCOP - Wichita
 Shaker Dakhil, MD, FACP
Ph: 316-262-4467
 Via Christi Cancer Center at Via Christi Regional Medical Center
 Shaker Dakhil, MD, FACP
Ph: 316-262-4467
 Wesley Medical Center
 Shaker Dakhil, MD, FACP
Ph: 316-262-4467
  Winfield
 Cancer Center of Kansas, PA - Winfield
 Shaker Dakhil, MD, FACP
Ph: 316-262-4467
Kentucky
  Lexington
 Lucille P. Markey Cancer Center at University of Kentucky
 Clinical Trials Office - Markey Cancer Center at University of Kentucky Chandler Medical Center
Ph: 859-257-3379
  Louisville
 Norton Suburban Hospital
 Mark Cornett
Ph: 502-893-1000
Louisiana
  Alexandria
 Tulane Cancer Center Office of Clinical Research
 Clinical Trials Office - Tulane Cancer Center
Ph: 504-988-6121
  Baton Rouge
 Mary Bird Perkins Cancer Center - Baton Rouge
 Robert Veith
Ph: 225-767-0847
  New Orleans
 CCOP - Ochsner
 Troy Scroggins, MD
Ph: 504-842-3440
 MBCCOP - LSU Health Sciences Center
 Robert Veith
Ph: 504-568-5151
 Medical Center of Louisiana - New Orleans
 Robert Veith
Ph: 504-903-2311
Maryland
  Annapolis
 DeCesaris Cancer Institute at Anne Arundel Medical Center
 Angel Torano, MD
Ph: 443-481-5800
  Baltimore
 Greater Baltimore Medical Center Cancer Center
 Clinical Trials Office - Greater Baltimore Medical Center Cancer Center
Ph: 443-849-3706
 St. Agnes Hospital Cancer Center
 Richard Hudes, MD
Ph: 410-368-2965
  Silver Spring
 Holy Cross Hospital
 Clinical Trials Office - Holy Cross Hospital
Ph: 310-754-7552
Massachusetts
  Boston
 Beth Israel Deaconess Medical Center
 Clinical Trials Office - Beth Israel Deaconess Medical Center
Ph: 617-667-9925
 Boston University Cancer Research Center
 Clinical Trials Office - Boston University Cancer Research Center
Ph: 617-638-8265
 Dana-Farber/Brigham and Women's Cancer Center
 Clinical Trials Office
Ph: 617-724-5200
 Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
 William Shipley, MD, FACR
Ph: 617-726-8146
 Massachusetts General Hospital
 Clinical Trials Office - Massachusetts General Hospital
Ph: 877-726-5130
  Fall River
 Hudner Oncology Center at Saint Anne's Hospital - Fall River
 Clinical Trials Office - Hudner Oncology Center at Saint Anne's Hospital - Fall River
Ph: 508-674-5600 ext. 2019
  Hyannis
 Cape Cod Hospital
 Daniel Canaday
Ph: 508-771-1800
  Mansfield
 Shields Radiation Oncology Center - Mansfield
 Bruce Bornstein
Ph: 617-376-6400
  Winchester
 Winchester Hospital Radiation Oncology Center
 Bruce Bornstein
Ph: 781-756-8300
Michigan
  Adrian
 Hickman Cancer Center at Bixby Medical Center
 Clinical Trials Office - Hickman Cancer Center at Bixby Medical Center
Ph: 517-265-0116
  Ann Arbor
 CCOP - Michigan Cancer Research Consortium
 Swati Dutta
Ph: 877-590-5995
 Saint Joseph Mercy Cancer Center
 Swati Dutta
Ph: 734-712-5658
888-474-4673
 University of Michigan Comprehensive Cancer Center
 Clinical Trials Office - University of Michigan Comprehensive Cancer Center
Ph: 800-865-1125
  Clinton Township
 Henry Ford Macomb Hospital
 Eleanor Walker, MD
Ph: 313-916-1021
  Commerce
 Charach Cancer Center at Huron Valley - Sinai Hospital
 Jordan Maier
Ph: 248-937-3300
  Dearborn
 Oakwood Cancer Center at Oakwood Hospital and Medical Center
 Clinical Trials Office - Oakwood Cancer Center at Oakwood Hospital and Medical Center
Ph: 313-593-8090
  Detroit
 Barbara Ann Karmanos Cancer Institute
 Clinical Trials Office - Barbara Ann Karmanos Cancer Institute
Ph: 313-576-9363
 Josephine Ford Cancer Center at Henry Ford Hospital
 Eleanor Walker, MD
Ph: 313-916-1021
  Flint
 Genesys Hurley Cancer Institute
 Clinical Trials Office - Genesys Hurley Cancer Institute
Ph: 810-762-8057
 Great Lakes Cancer Institute at McLaren Regional Medical Center
 Clinical Trials Office - Great Lakes Cancer Institute at McLaren Regional Medical Center
Ph: 810-342-4071
 Hurley Medical Center
 Clinical Trials Office - Hurley Medical Center
Ph: 810-762-8057
  Grosse Pointe Woods
 Van Elslander Cancer Center at St. John Hospital and Medical Center
 Clincial Trials Office - Van Elslander Cancer Center at St. John Hospital and Medical Center
Ph: 313-343-3166
  Jackson
 Foote Memorial Hospital
 Swati Dutta
Ph: 517-788-4800
  Kalamazoo
 Borgess Medical Center
 Raymond Lord, MD
Ph: 269-373-7458
 Bronson Methodist Hospital
 Raymond Lord, MD
Ph: 269-373-7458
 West Michigan Cancer Center
 Clinical Trials Office - West Michigan Cancer Center
Ph: 269-373-7458
  Lansing
 Sparrow Regional Cancer Center
 Clinical Trials Office - Sparrow Regional Cancer Center
Ph: 517-364-2890
  Livonia
 St. Mary Mercy Hospital
 Swati Dutta
Ph: 734-464-4800
  Pontiac
 St. Joseph Mercy Oakland
 Swati Dutta
Ph: 248-858-3612
  Port Huron
 Mercy Regional Cancer Center at Mercy Hospital
 Swati Dutta
Ph: 810-985-1484
  Royal Oak
 William Beaumont Hospital - Royal Oak Campus
 Clinical Trials Office - William Beaumont Hospital - Royal Oak Campus
Ph: 248-551-7695
  Saginaw
 Seton Cancer Institute at Saint Mary's - Saginaw
 Clinical Trials Office - Seton Cancer Institute - Saginaw
Ph: 989-776-8411
  St. Joseph
 Lakeland Regional Cancer Care Center - St. Joseph
 David Hornback, MD
Ph: 574-647-7461
  Warren
 St. John Macomb Hospital
 Swati Dutta
Ph: 586-573-5757
888-593-2237
Minnesota
  Bemidji
 MeritCare Bemidji
 Preston Steen, MD
Ph: 701-234-2397
  Duluth
 CCOP - Duluth
 Daniel Nikcevich, MD, PhD
Ph: 218-786-3625
 Duluth Clinic Cancer Center - Duluth
 Clinical Trials Office - Duluth Clinic Cancer Center - Duluth
Ph: 218-786-3308
 Miller - Dwan Medical Center
 Daniel Nikcevich, MD, PhD
Ph: 218-786-3625
 St. Luke's Hospital Cancer Care Center
 Steven Bonin
Ph: 218-249-7800
877-249-7800
  Mankato
 Immanuel St. Joseph's
 Ron Smith
Ph: 507-345-2929
  Rochester
 Mayo Clinic Cancer Center
 Clinical Trials Office - All Mayo Clinic Locations
Ph: 507-538-7623
Mississippi
  Pascagoula
 Regional Cancer Center at Singing River Hospital
 James Clarkson, MD
Ph: 228-374-6296
Missouri
  Cape Girardeau
 Cancer Institute of Cape Girardeau, LLC
 Tapan Roy, MD
Ph: 573-334-2230
  Saint Louis
 Barnes-Jewish West County Hospital
 Jeff Michalski, MD
Ph: 314-362-8566
 Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
 Jeff Michalski, MD
Ph: 314-362-8566
  Saint Peters
 Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - St. Peters
 Jeff Michalski, MD
Ph: 314-362-8566
Montana
  Billings
 Billings Clinic - Downtown
 Clinical Trials Office - Billings Clinic - Downtown
Ph: 800-996-2663
  Email: research@billingsclinic.org
 CCOP - Montana Cancer Consortium
 Benjamin Marchello, MD
Ph: 406-238-6290
  Bozeman
 Bozeman Deaconess Cancer Center
 Benjamin Marchello, MD
Ph: 406-238-6290
  Great Falls
 Great Falls Clinic - Main Facility
 Benjamin Marchello, MD
Ph: 406-238-6290
 Sletten Cancer Institute at Benefis Healthcare
 Grant Harrer, MD, FACP, CCTI
Ph: 406-731-8100
Nebraska
  Lincoln
 Cancer Resource Center - Lincoln
 Gamini Soori, MD, FACP, FRCP, MBA
Ph: 402-393-3110
 Saint Elizabeth Cancer Institute at Saint Elizabeth Regional Medical Center
 Clinical Trials Office - Saint Elizabeth Cancer Institute at Saint Elizabeth Regional Medical Center
Ph: 402-483-2827
  Omaha
 Alegant Health Cancer Center at Bergan Mercy Medical Center
 Clinical Trials Office - Alegant Health Cancer Center at Bergen Mercy Medical Center
Ph: 402-398-6060
 CCOP - Missouri Valley Cancer Consortium
 Gamini Soori, MD, FACP, FRCP, MBA
Ph: 402-393-3110
 Creighton University Medical Center
 Clinical Trials Office - Creighton University Medical Center
Ph: 402-280-4100
 Immanuel Medical Center
 Gamini Soori, MD, FACP, FRCP, MBA
Ph: 402-393-3110
 Lakeside Hospital
 Gamini Soori, MD, FACP, FRCP, MBA
Ph: 402-393-3110
 Methodist Estabrook Cancer Center
 Tien-Shew Huang
Ph: 402-354-5890
877-850-3212
Nevada
  Las Vegas
 CCOP - Nevada Cancer Research Foundation
 John Ellerton, MD, CM
Ph: 702-384-0013
New Hampshire
  Exeter
 Center for Cancer Care at Exeter Hospital
 Gary Proulx
Ph: 570-882-4048
  Keene
 Kingsbury Center for Cancer Care at Cheshire Medical Center
 Alan Hartford, MD, PhD
Ph: 603-650-6600
  Lebanon
 Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
 Clinical Trials Office - Norris Cotton Cancer Center
Ph: 603-650-7609
  Email: cancerhelp@dartmouth.edu
New Jersey
  Basking Ridge
 Memorial Sloan-Kettering Cancer Center - Basking Ridge
 Michael Zelefsky
Ph: 908-542-3000
  Freehold
 CentraState Medical Center
 Edward Soffen, MD
Ph: 609-497-4304
  Marlton
 Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
 Clinical Trials Office - Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
Ph: 888-847-8823
  Pennington
 Capital Health Regional Cancer Center
 Shirnett Williamson, MD
Ph: 340-775-5433
  Pomona
 AtlantiCare Cancer Care Institute at AtlantiCare Regional Medical Center - Mainland Campus
 James Wurzer
Ph: 609-652-1000
  Ridgewood
 Valley Hospital - Ridgewood
 Michael Wesson
Ph: 201-634-5339
  Somerville
 Somerset Medical Center
 Clinical Trials Office - Somerset Medical Center
Ph: 908-685-2481
  Sparta
 Frederick R. and Betty M. Smith Cancer Treatment Center
 Adam Dicker, MD, PhD
Ph: 215-955-6527
  Vineland
 Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare
 Clinical Trials Office - Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare
Ph: 856-641-7933
  Voorhees
 Cancer Institute of New Jersey at Cooper - Voorhees
 Clinical Trials Office - Cancer Institute of New Jersey at Cooper University Hospital - Voorhees
Ph: 856-325-6757
 Fox Chase Virtua Health Cancer Program at Virtua West Jersey
 Lemuel Ariaratnam, MD
Ph: 609-261-7074
New Mexico
  Albuquerque
 Lovelace Medical Center - Downtown
 Ian Rabinowitz, MD
Ph: 505-272-4551
 Radiation Oncology Associates, PA
 Ian Rabinowitz, MD
Ph: 505-272-4551
 University of New Mexico Cancer Center
 Clinical Trials Office - University of New Mexico Cancer Center
Ph: 505-272-6972
  Las Cruces
 University of New Mexico Cancer Center - South
 Ian Rabinowitz, MD
Ph: 505-272-4551
New York
  Albany
 New York Oncology Hematology, PC at Albany Regional Cancer Care
 Vivek Kavadi
Ph: 518-489-2607
  Bronx
 Lincoln Medical and Mental Health Center
 Aubrey Freiberg
Ph: 718-579-5000
  Brooklyn
 Kings County Hospital Center
 Marvin Rotman, MD
Ph: 718-270-2181
 Long Island College Hospital
 Marvin Rotman, MD
Ph: 718-270-2181
 SUNY Downstate Medical Center
 Marvin Rotman, MD
Ph: 718-270-2181
 Veterans Affairs Medical Center - Brooklyn
 David Schwartz
Ph: 718-630-3574
  Buffalo
 Roswell Park Cancer Institute
 Clinical Trials Office - Roswell Park Cancer Institute
Ph: 877-275-7724
  Canandiaqua
 Sands Cancer Center
 Yuhchyau Chen
Ph: 585-396-6161
877-620-6161
  Commack
 Memorial Sloan-Kettering Cancer Center
 Michael Zelefsky
Ph: 212-639-8895
800-525-2225
  New York
 Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
 Clinical Trials Office - Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
Ph: 212-305-8615
 Memorial Sloan-Kettering Cancer Center
 Michael Zelefsky
Ph: 212-639-8895
800-525-2225
 St. Luke's - Roosevelt Hospital Center - St.Luke's Division
 Ronald Ennis
Ph: 212-523-4000
 Stich Radiation Center at NewYork-Presbyterian Hospital/Weill Cornell Medical Center
 Michael Smith
Ph: 212-746-3610
  Poughkeepsie
 Hudson Valley Oncology Associates
 Adam Dicker, MD, PhD
Ph: 215-955-6527
  Rochester
 Highland Hospital of Rochester
 Yuhchyau Chen
Ph: 585-473-2200
 James P. Wilmot Cancer Center at University of Rochester Medical Center
 Yuhchyau Chen
Ph: 585-275-5345
 Lipson Cancer and Blood Center at Rochester General Hospital
 Meri Atanas
Ph: 585-922-4020
 University Radiation Oncology at Parkridge Hospital
 Yuhchyau Chen
Ph: 585-225-3989
  Rockville Centre
 Memorial Sloan-Kettering Cancer Center - Rockville Centre
 Michael Zelefsky
Ph: 516-256-3651
  Sleepy Hollow
 Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center
 Michael Zelefsky
Ph: 914-366-3000
North Carolina
  Asheboro
 Randolph Hospital
 Clinical Trails Office - Randolph Hospital
Ph: 336-832-0821
  Asheville
 Mission Hospitals - Memorial Campus
 Clinical Trials Office - Mission Hospitals - Memorial Campus
Ph: 828-213-4150
  Charlotte
 Blumenthal Cancer Center at Carolinas Medical Center
 Clinical Trials Office - Blumenthal Cancer Center at Carolinas Medical Center
Ph: 704-355-2884
  Greensboro
 Moses Cone Regional Cancer Center at Wesley Long Community Hospital
 Clinical Trials Office - Moses Cone Regional Cancer Center at Wesley Long Community Hospital
Ph: 336-621-8374
  Morehead City
 Coleman Radiation Oncology Center at Carter General Hospital
 Michael Papagikos
Ph: 252-808-6191
  New Bern
 CarolinaEast Cancer Care
 Michael Papagikos
Ph: 252-633-8790
  Pinehurst
 FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
 Clinical Trials Office - FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
Ph: 910-715-2200
  Raleigh
 Cancer Centers of North Carolina - Raleigh
 Vivek Kavadi
Ph: 919-781-7070
 Rex Cancer Center at Rex Hospital
 Clinical Trials Office - Rex Cancer Center
Ph: 919-784-7209
  Reidsville
 Annie Penn Cancer Center
 Clinical Trials Office - Annie Penn Cancer Center
Ph: 336-621-8374
  Supply
 South Atlantic Radiation Oncology, LLC
 Michael Papagikos
Ph: 910-754-4716
  Wilmington
 Coastal Carolina Radiation Oncology Center
 Michael Papagikos
Ph: 910-251-1839
 Zimmer Cancer Center at New Hanover Regional Medical Center
 Michael Papagikos
Ph: 910-342-3000
877-228-8135
  Winston-Salem
 Wake Forest University Comprehensive Cancer Center
 Clinical Trials Office - Wake Forest University Comprehensive Cancer Center
Ph: 336-713-6771
North Dakota
  Fargo
 CCOP - MeritCare Hospital
 Preston Steen, MD
Ph: 701-234-2397
 MeritCare Broadway
 Preston Steen, MD
Ph: 701-234-2397
 Roger Maris Cancer Center at MeritCare Hospital
 Preston Steen, MD
Ph: 701-234-2397
  Grand Forks
 Altru Cancer Center at Altru Hospital
 Clinical Trails Office - Altru Cancer Center at Altru Hospital
Ph: 701-780-6520
Ohio
  Akron
 McDowell Cancer Center at Akron General Medical Center
 Mitchell Fromm, MD
Ph: 330-344-6448
 Summa Center for Cancer Care at Akron City Hospital
 Clinical Trials Office - Akron City Hospital
Ph: 330-375-6101
  Barberton
 Barberton Citizens Hospital
 William Demas, MD
Ph: 330-375-3557
  Canton
 Aultman Cancer Center at Aultman Hospital
 Clinical Trials Office - Aultman Cancer Center at Aultman Hospital
Ph: 330-363-6891
  Chillicothe
 Adena Regional Medical Center
 Clinical Trials Office - Adena Regional Medical Center
Ph: 877-779-7585
  Cincinnati
 Charles M. Barrett Cancer Center at University Hospital
 Kevin Redmond, MD
Ph: 513-584-9089
  Cleveland
 Case Comprehensive Cancer Center
 Clinical Trials Office - Case Comprehensive Cancer Center
Ph: 800-641-2422
 Cleveland Clinic Cancer Center at Fairview Hospital
 Clinical Trials Office - Cleveland Clinic Cancer Center at Fairview Hospital
Ph: 216-476-9362
 Cleveland Clinic Taussig Cancer Center
 Clinical Trials Office - Cleveland Clinic Taussig Cancer Center
Ph: 866-223-8100
  Columbus
 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
 Ohio State University Cancer Clinical Trial Matching Service
Ph: 866-627-7616
  Email: osu@emergingmed.com
 CCOP - Columbus
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
 Doctors Hospital at Ohio Health
 Clinical Trials Office - Doctors Hospital at Ohio Health
Ph: 614-566-3275
 Grant Medical Center Cancer Care
 Clinical Trials Office - Grant Medical Center Cancer Care
Ph: 614-566-4475
 Mount Carmel Health - West Hospital
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
 Riverside Methodist Hospital Cancer Care
 Clinical Trials Office - Riverside Methodist Hospital Cancer Care
Ph: 614-566-4475
  Delaware
 Grady Memorial Hospital
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Elyria
 Community Cancer Center
 Rex Mowat
Ph: 440-324-0400
 Hematology Oncology Center
 Rex Mowat
Ph: 440-324-0401
  Independence
 Cleveland Clinic Cancer Center
 Rahul Tendulkar
Ph: 216-524-7979
  Lima
 Lima Memorial Hospital
 Rex Mowat
Ph: 419-228-3335
  Marietta
 Strecker Cancer Center at Marietta Memorial Hospital
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Maumee
 Northwest Ohio Oncology Center
 Rex Mowat
Ph: 419-891-5600
  Mayfield Heights
 Hillcrest Cancer Center at Hillcrest Hospital
 Rahul Tendulkar
Ph: 440-312-4500
  Mentor
 Lake/University Ireland Cancer Center
 Robert Fine
Ph: 440-205-5755
  Middleburg Heights
 Southwest General Health Center
 Robert Fine
Ph: 440-816-8000
  Newark
 Licking Memorial Cancer Care Program at Licking Memorial Hospital
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Orange Village
 UHHS Chagrin Highlands Medical Center
 Robert Fine
Ph: 216-292-1783
  Oregon
 St. Charles Mercy Hospital
 Rex Mowat
Ph: 419-696-7200
  Parma
 Parma Community General Hospital
 Clinical Trials Office - Parma Community General Hospital
Ph: 440-743-4747
  Salem
 Cancer Care Center, Incorporated
 William Demas, MD
Ph: 330-375-3557
  Sandusky
 North Coast Cancer Care, Incorporated
 Rex Mowat
Ph: 419-626-9090
  Springfield
 Community Hospital of Springfield and Clark County
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Sylvania
 Flower Hospital Cancer Center
 Clinical Trials Office - Flower Hospital Cancer Center
Ph: 419-824-1842
  Tiffin
 Mercy Hospital of Tiffin
 Rex Mowat
Ph: 419-447-3130
  Toledo
 CCOP - Toledo Community Hospital
 Rex Mowat
Ph: 419-843-6147
 Medical University of Ohio Cancer Center
 Clinical Trials Office - Medical University of Ohio Cancer Center
Ph: 419-383-6583
 St. Anne Mercy Hospital
 Rex Mowat
Ph: 419-407-2663
 St. Vincent Mercy Medical Center
 Rex Mowat
Ph: 419-251-4515
 Toledo Clinic, Incorporated - Main Clinic
 Rex Mowat
Ph: 419-479-5605
 Toledo Hospital
 Clinical Trials Office - Toledo Hospital
Ph: 419-824-1842
  West Chester
 Precision Radiotherapy at University Pointe
 Kevin Redmond, MD
Ph: 513-584-9089
  Westerville
 Mount Carmel St. Ann's Cancer Center
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Westlake
 UHHS Westlake Medical Center
 Robert Fine
Ph: 440-250-2001
  Wooster
 Cancer Treatment Center
 Clinical Trials Office - Cancer Treatment Center
Ph: 330-375-4221
 Cleveland Clinic - Wooster
 Clinical Trials Office - Cleveland Clinic - Wooster
Ph: 800-862-7798
  Zanesville
 Genesis - Good Samaritan Hospital
 Clinical Trials Office - Genesis - Good Samaritan Hospital
Ph: 740-454-5232
Oklahoma
  Oklahoma City
 Oklahoma University Cancer Institute
 Terence Herman
Ph: 405-271-6822
  Tulsa
 Natalie Warren Bryant Cancer Center at St. Francis Hospital
 Charles Stewart
Ph: 918-494-2273
Oregon
  Eugene
 Willamette Valley Cancer Center - Eugene
 Vivek Kavadi
Ph: 541-683-5001
  Grants Pass
 Three Rivers Community Hospital
 Gordon Metz, MD
Ph: 541-608-4263
  Medford
 Dubs Cancer Center at Rogue Valley Medical Center
 Gordon Metz, MD
Ph: 541-608-4263
 Providence Cancer Center at PMCC
 Gordon Metz, MD
Ph: 541-608-4263
  Salem
 Salem Hospital Regional Cancer Care Services
 Clinical Trials Office - Salem Hospital Regional Cancer Care Services
Ph: 503-561-2618
Pennsylvania
  Abington
 Rosenfeld Cancer Center at Abington Memorial Hospital
 Clinical Trials Office - Rosenfeld Cancer Center at Abington Memorial Hospital
Ph: 215-481-2402
  Beaver
 UPMC Cancer Center at Beaver Medical Center
 Ryan Smith, MD
Ph: 412-623-3205
  Bethlehem
 St. Luke's Cancer Network at St. Luke's Hospital
 Nimisha Deb, MD
Ph: 610-954-4300
  Clairton
 UPMC Cancer Center at Jefferson Regional Medical Center
 Ryan Smith, MD
Ph: 412-623-3205
  Danville
 Geisinger Cancer Institute at Geisinger Health
 Clinical Trials Office - Geisinger Cancer Institute
Ph: 570-271-5251
  Drexel Hill
 Delaware County Regional Cancer Center at Delaware County Memorial Hospital
 Rachelle Lanciano, MD
Ph: 610-284-8240
  Dunmore
 Northeast Radiation Oncology Center
 Adam Dicker, MD, PhD
Ph: 215-955-6527
  Gettysburg
 Adams Cancer Center
 Amit Shah
Ph: 717-741-8180
  Greensburg
 UPMC Cancer Center - Arnold Palmer Pavilion
 Ryan Smith, MD
Ph: 412-623-3205
  Hershey
 Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
 Clinical Trials Office - Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
Ph: 717-531-3779
  Email: CTO@hmc.psu.edu
  Johnstown
 UPMC Cancer Center at the John P. Murtha Pavilion
 Ryan Smith, MD
Ph: 412-623-3205
  Lancaster
 Lancaster General Hospital
 Jeffery Eshleman
Ph: 717-544-5511
  Langhorne
 St. Mary Regional Cancer Center
 Clinical Trials Office - St. Mary Regional Cancer Center
Ph: 215-710-4585
  McKeesport
 UPMC Cancer Center at UPMC McKeesport
 Clinical Trials Office - UPMC Cancer Center at UPMC McKeesport
Ph: 412-647-8073
  Milford
 Upper Delaware Valley Cancer Center
 Adam Dicker, MD, PhD
Ph: 215-955-6527
  Moon Township
 UPMC - Moon
 Ryan Smith, MD
Ph: 412-623-3205
  Natrona Heights
 UPMC Cancer Center - Natrona Heights
 Ryan Smith, MD
Ph: 412-623-3205
  New Castle
 Jameson Memorial Hospital - North Campus
 Ryan Smith, MD
Ph: 412-623-3205
  Philadelphia
 Fox Chase Cancer Center - Philadelphia
 Clinical Trials Office - Fox Chase Cancer Center - Philadelphia
Ph: 215-728-4790
 Frankford Hospital Cancer Center - Torresdale Campus
 Adam Dicker, MD, PhD
Ph: 215-955-6527
 Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
 Clinical Trials Office - Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Ph: 215-955-6084
  Pittsburgh
 UPMC - Shadyside
 Clinical Trials Office - UPMC - Shadyside
Ph: 412-621-2334
 UPMC Cancer Center - Upper St. Clair
 Ryan Smith, MD
Ph: 412-623-3205
 UPMC Cancer Center at Magee-Womens Hospital
 Clinical Trials Office - UPMC Cancer Center at Magee-Womens Hospital
Ph: 412-647-2811
 UPMC Cancer Center at UPMC Passavant
 Clinical Trials Office - UPMC Cancer Center at UPMC Passavant
Ph: 412-367-6454
 UPMC Cancer Center at UPMC Presbyterian
 Clinical Trial Office - UPMC Cancer Center at UPMC Presbyterian
Ph: 412-647-2811
 UPMC Cancer Center at UPMC St. Margaret
 Ryan Smith, MD
Ph: 412-623-3205
  Reading
 McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
 Clinical Trials Office - McGlinn Family Regional Cancer Center
Ph: 610-988-9323
 St. Joseph Medical Center
 Leonard Tuanquin
Ph: 610-378-2000
  Uniontown
 UPMC Cancer Center - Uniontown
 Ryan Smith, MD
Ph: 412-623-3205
  Upland
 Crozer-Chester Medical Center
 Stephen Arrigo
Ph: 610-447-2000
  Washington
 Washington Hospital Cancer Center
 Ryan Smith, MD
Ph: 412-623-3205
  Wilkes-Barre
 Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
 Clinical Trials Office - Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
Ph: 570-271-5251
  York
 York Cancer Center at Apple Hill Medical Center
 Amit Shah
Ph: 717-741-8180
South Carolina
  Anderson
 AnMed Cancer Center
 Clinical Trials Office - AnMed Cancer Center
Ph: 864-512-1000
  Charleston
 Hollings Cancer Center at Medical University of South Carolina
 Clinical Trials Office - Hollings Cancer Center at Medical University of South Carolina
Ph: 843-792-9321
  Greenville
 Cancer Centers of the Carolinas - Eastside
 Clinical Trials Office - Cancer Centers of the Carolinas
Ph: 864-241-6251
 Cancer Centers of the Carolinas - Faris Road
 Jeffrey Giguere, MD, FACP
Ph: 864-987-7000
 Cancer Centers of the Carolinas - Grove Commons
 Clinical Trials Office - Cancer Centers of the Carolinas
Ph: 864-241-6251
 CCOP - Greenville
 Jeffrey Giguere, MD, FACP
Ph: 864-987-7000
  Greer
 Cancer Centers of the Carolinas - Greer Medical Oncology
 Jeffrey Giguere, MD, FACP
Ph: 864-987-7000
  Seneca
 Cancer Centers of the Carolinas - Seneca
 Jeffrey Giguere, MD, FACP
Ph: 864-987-7000
  Spartanburg
 Cancer Centers of the Carolinas - Spartanburg
 Jeffrey Giguere, MD, FACP
Ph: 864-987-7000
 CCOP - Upstate Carolina
 Clinical Trials Office - CCOP - Upstate Carolina
Ph: 800-486-5941
 Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
 Clinical Trials Office - Gibbs Regional Cancer Center
Ph: 800-486-5941
South Dakota
  Rapid City
 Rapid City Regional Hospital
 Michael Swartz
Ph: 605-719-2360
Texas
  Bedford
 Texas Oncology, PA at Harris Center HEB
 Vivek Kavadi
Ph: 817-359-9000
  Dallas
 Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
 Clinical Trials Office - Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Ph: 866-460-4673; 214-648-7097
  Denton
 Texas Oncology, PA at Texas Cancer Center - Denton South
 Vivek Kavadi
Ph: 940-382-1022
  Fort Worth
 Klabzuba Cancer Center at Harris Methodist Fort Worth Hospital
 Vivek Kavadi
Ph: 817-820-4820
  Galveston
 University of Texas Medical Branch
 Clinical Trials Office - University of Texas Medical Branch
Ph: 409-772-1950
  Longview
 Longview Cancer Center
 Vivek Kavadi
Ph: 903-757-2122
  Odessa
 West Texas Cancer Center
 Vivek Kavadi
Ph: 432-335-8275
  San Antonio
 Cancer Care Centers of South Texas - Northeast
 Vivek Kavadi
Ph: 210-656-7177
  Sherman
 Texas Oncology, PA at Texas Cancer Center - Sherman
 Vivek Kavadi
Ph: 903-892-9455
  Sugar Land
 Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
 Vivek Kavadi
Ph: 281-277-5200
  Tyler
 Tyler Cancer Center
 Vivek Kavadi
Ph: 903-579-9800
  Wichita Falls
 Texas Oncology, PA - Wichita Falls
 Vivek Kavadi
Ph: 940-767-4364
Utah
  Cedar City
 Sandra L. Maxwell Cancer Center
 R. Jeffrey Lee, MD
Ph: 801-408-1146
  Logan
 Logan Regional Hospital
 R. Jeffrey Lee, MD
Ph: 801-408-1146
  Murray
 Jon and Karen Huntsman Cancer Center at Intermountain Medical Center
 R. Jeffrey Lee, MD
Ph: 801-408-1146
  Ogden
 Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
 Clinical Trials Office - McKay-Dee Hospital Center
Ph: 801 387-7426
  Provo
 Utah Valley Regional Medical Center - Provo
 Clinical Trials Office - Utah Valley Regional Medical Center - Provo
Ph: 801-357-7965
  Saint George
 Dixie Regional Medical Center - East Campus
 Clinical Trials Office - Dixie Regional Medical Center - East Campus
Ph: 435-688-4167
  Salt Lake City
 Huntsman Cancer Institute at University of Utah
 Clinical Trials Office - Huntsman Cancer Institute at University of Utah
Ph: 801-581-4477
  Email: clinical.trials@hci.utah.edu
 LDS Hospital
 R. Jeffrey Lee, MD
Ph: 801-408-1146
 Utah Cancer Specialists at UCS Cancer Center
 R. Jeffrey Lee, MD
Ph: 801-408-1146
Vermont
  Burlington
 Fletcher Allen Health Care - University Health Center Campus
 Clinical Trials Office - Fletcher Allen Health Care
Ph: 802-656-8990
  Saint Johnsbury
 Norris Cotton Cancer Center - North
 Alan Hartford, MD, PhD
Ph: 603-650-6600
Virginia
  Alexandria
 INOVA Alexandria Hospital
 Matthew Poggi
Ph: 703-504-3000
  Charlottesville
 Martha Jefferson Hospital Cancer Care Center
 Sylvia Hendrix, MD
Ph: 434-982-8125
  Danville
 Danville Regional Medical Center
 Clinical Trials Office - Danville Regional Medical Center
Ph: 434-799-3753
  Portsmouth
 Naval Medical Center - Portsmouth
 Clinical Trials Office - Naval Medical Center - Portsmouth
Ph: 757-953-5939
  Richmond
 Veterans Affairs Medical Center - Richmond
 Clinical Trials Office - Veterans Affairs Medical Center - Richmond
Ph: 804-675-5646
Washington
  Bellingham
 St. Joseph Cancer Center
 Michael Taylor, MD
Ph: 360-715-4144
  Bremerton
 Harrison Medical Center
 Stephen Springate
Ph: 360-792-6605
  Federal Way
 St. Francis Hospital
 Yoshio Inoue
Ph: 253-944-7997
  Puyallup
 Good Samaritan Cancer Center
 Yoshio Inoue
Ph: 253-697-4000
  Seattle
 CCOP - Virginia Mason Research Center
 Huong Pham, MD
Ph: 206-223-6801
 Seattle Cancer Care Alliance
 Clinical Trials Office - Seattle Cancer Care Alliance
Ph: 800-804-8824
 University Cancer Center at University of Washington Medical Center
 George Laramore, PhD, MD, FACR
Ph: 206-598-4110
 Virginia Mason Medical Center
 Huong Pham, MD
Ph: 206-223-6801
  Spokane
 Cancer Care Northwest - Spokane South
 Clinical Trials Office - Cancer Care Northwest - Spokane South
Ph: 509-228-1083
  Tacoma
 CCOP - Northwest
 Yoshio Inoue
Ph: 253-403-1461
 Franciscan Cancer Center at St. Joseph Medical Center
 Clinical Trials Office - Franciscan Cancer Center
Ph: 253-426-6914
 MultiCare Regional Cancer Center at Tacoma General Hospital
 Clinical Trials Office - MultiCare Regional Cancer Center
Ph: 253-403-3229
  Wenatchee
 Wenatchee Valley Medical Center
 Clinical Trials Office - Wenatchee Valley Medical Center
Ph: 509-665-5800
  Yakima
 North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
 Clinical Trails Office - North Star Lodge Cancer Center
Ph: 509-574-3422
West Virginia
  Charleston
 West Virginia University Health Sciences Center - Charleston
 Steven Jubelirer, MD
Ph: 304-388-8380
Wisconsin
  Antigo
 Langlade Memorial Hospital
 Darryl Barton, MD
Ph: 715-847-2866
  Appleton
 Theda Care Cancer Institute
 Clinical Trials Office - Theda Care Cancer Institute
Ph: 920-380-1500
  Beloit
 Beloit Memorial Hospital
 Mark Ritter
Ph: 608-364-5011
  Fond du Lac
 Central Wisconsin Cancer Program at Agnesian HealthCare
 Clinical Trials Office - Central Wisconsin Cancer Program at Agnesian HealthCare
Ph: 800-494-2927
  Green Bay
 Bellin Memorial Hospital
 Charlie Pan
Ph: 920-433-3500
 St. Vincent Hospital Regional Cancer Center
 Clinical Trials Office - St. Vincent Hospital Regional Cancer Center
Ph: 920-433-8889
  Johnson Creek
 UW Cancer Center Johnson Creek
 Mark Ritter
Ph: 920-699-3500
  La Crosse
 Franciscan Skemp Healthcare - La Crosse Campus
 Kernan Minehan, MD
Ph: 608-791-9510
 Gundersen Lutheran Center for Cancer and Blood
 Clinical Trials Office - Gundersen Lutheran Cancer Center
Ph: 608-775-2385
  Email: cancerctr@gundluth.org
  Madison
 University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
 Clinical Trials Office - University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Ph: 608-262-5223
  Marinette
 Bay Area Cancer Care Center at Bay Area Medical Center
 Gregory Cooley, MD
Ph: 414-433-8184
  Menomonee Falls
 Community Memorial Hospital Cancer Care Center
 Colleen Lawton, MD
Ph: 414-805-4472
  Mequon
 Columbia Saint Mary's Hospital - Ozaukee
 Carl Olson, MD
Ph: 414-291-1556
  Milwaukee
 Columbia-Saint Mary's Cancer Care Center
 Clinical Trials Office - Columbia-St. Mary's Cancer Care Center
Ph: 414-326-1739
 Medical College of Wisconsin Cancer Center
 Clinical Trials Office - Medical College of Wisconsin Cancer Center
Ph: 414-805-4380
 Veterans Affairs Medical Center - Milwaukee
 Elizabeth Gore, MD
Ph: 414-805-4369
 Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center
 Clinical Trials Office - Vince Lombardi Cancer Clinic
Ph: 414-649-5717
  Mukwonago
 D.N. Greenwald Center
 Wingate Clapper, MD
Ph: 262-928-2439
  Oconomowoc
 Regional Cancer Center at Oconomowoc Memorial Hospital
 Clinical Trials Office - Regional Cancer Center at Oconomowoc Memorial Hospital
Ph: 262-928-7878
  Racine
 All Saints Cancer Center at Wheaton Franciscan Healthcare
 James Taylor, MD
Ph: 262-687-5000
  Sturgeon Bay
 Door County Cancer Center at Door County Memorial Hospital
 Gregory Cooley, MD
Ph: 414-433-8184
  Summit
 Aurora Medical Center
 Ellen Ziaja
Ph: 262-434-1000
  Waukesha
 Waukesha Memorial Hospital Regional Cancer Center
 Clinical Trials Office - Waukesha Memorial Hospital Regional Cancer Center
Ph: 262-928-7632
  Wausau
 University of Wisconcin Cancer Center at Aspirus Wausau Hospital
 Clinical Trials Office - University of Wisconsin Cancer Center
Ph: 608-262-5223
  West Allis
 West Allis Memorial Hospital
 Clinical Trials Office - West Allis Memorial Hospital
Ph: 414-649-5717
  Wisconsin Rapids
 Riverview UW Cancer Center at Riverview Hospital
 Mark Ritter
Ph: 715-421-7442
Wyoming
  Sheridan
 Welch Cancer Center at Sheridan Memorial Hospital
 Benjamin Marchello, MD
Ph: 406-238-6290
Canada
Alberta
  Calgary
 Tom Baker Cancer Centre - Calgary
 Alexander Balogh
Ph: 403-521-3723
  Edmonton
 Cross Cancer Institute at University of Alberta
 Nawaid Usmani
Ph: 780-432-8771
New Brunswick
  Saint John
 Saint John Regional Hospital
 John Carson, MD
Ph: 506-648-6890
Newfoundland and Labrador
  Saint John's
 Doctor H. Bliss Murphy Cancer Centre
 Jonathan Greenland
Ph: 709-777-7589
Ontario
  Hamilton
 Margaret and Charles Juravinski Cancer Centre
 Himanshu Lukka
Ph: 905-387-9495
  Thunder Bay
 Cancer Care Program at Thunder Bay Regional Health Sciences
 Sunil Premial Gulavita
Ph: 807-684-7200
Quebec
  Montreal
 Hopital Notre-Dame du CHUM
 Marie-Claude Beauchemin
Ph: 514-281-6000
 Maisonneuve-Rosemont Hospital
 Nader Khaouam
Ph: 514-252-3400
 McGill Cancer Centre at McGill University
 Luis Souhami
Ph: 514-398-1444
  Quebec City
 Centre Hospitalier Universitaire de Quebec
 Andre-Guy Martin
Ph: 418-525-4444
  Sherbrooke
 CHUS-Hopital Fleurimont
 Abdenour Nabid, MD, FRCPC
Ph: 819-346-1110ext.14602
Saskatchewan
  Regina
 Allan Blair Cancer Centre at Pasqua Hospital
 Evgeny Sadikov
Ph: 306-766-2203
  Saskatoon
 Saskatoon Cancer Centre at the University of Saskatchewan
 Ali El-Gayed
Ph: 306-655-2662

Registry Information
Official Title A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy
Trial Start Date 2008-02-13
Trial Completion Date 2017-12-01 (estimated)
Registered in ClinicalTrials.gov NCT00567580
Date Submitted to PDQ 2007-11-12
Information Last Verified 2012-02-10
NCI Grant/Contract Number CA21661

Note: The purpose of most clinical trials listed in this database is to test new cancer treatments, or new methods of diagnosing, screening, or preventing cancer. Because all potentially harmful side effects are not known before a trial is conducted, dose and schedule modifications may be required for participants if they develop side effects from the treatment or test. The therapy or test described in this clinical trial is intended for use by clinical oncologists in carefully structured settings, and may not prove to be more effective than standard treatment. A responsible investigator associated with this clinical trial should be consulted before using this protocol.

Back to TopBack to Top